Articles published by Champions Oncology, Inc.
Via AccessWire
Tickers
CSBR
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022
July 14, 2022
Via AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics
May 31, 2022
Via AccessWire
Tickers
CSBR
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2022
March 11, 2022
Via AccessWire
Tickers
CSBR
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
February 15, 2022
Via AccessWire
Tickers
CSBR
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
December 13, 2021
Via AccessWire
Tickers
CSBR
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 13, 2021
December 06, 2021
Via AccessWire
Tickers
CSBR
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
September 13, 2021
Via AccessWire
Topics
Earnings
Exposures
Financial
Tickers
CSBR
Champions Oncology to Announce First Quarter Financial Results on Monday, September 13, 2021
September 02, 2021
Via AccessWire
Tickers
CSBR
Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development
July 26, 2021
Via AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Tickers
CSBR
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 22, 2021
July 14, 2021
Via AccessWire
Tickers
CSBR
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free